The aim of the present study is to investigate a potential relationship between the number of baseline ISDR/PKR-bd substitutions and the liver fibrosis stage and/or the development of HCC in SVR after treatment with DAAs. This evidence concerns the gene EIF2AK2 and hepatocellular carcinoma.